Azienda Ospedaliera Santa Maria Della Misericordia

Udine 33100

0 studies enrolling now · 3 studies all time

What they study most

Crohn's Disease, Systemic Lupus Erythematosus

Studies at this site

• A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Completed
• A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE) — Stopped early
• A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE-BRAVE II) — Completed